Phreesia Inc (PHR)
22.59
-0.09
(-0.40%)
USD |
NYSE |
May 07, 14:28
Phreesia Profit Margin (Quarterly): -32.26% for Jan. 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | -32.26% |
October 31, 2023 | -34.86% |
July 31, 2023 | -42.84% |
April 30, 2023 | -44.76% |
January 31, 2023 | -49.64% |
October 31, 2022 | -54.95% |
July 31, 2022 | -68.83% |
April 30, 2022 | -80.88% |
January 31, 2022 | -80.06% |
October 31, 2021 | -65.00% |
July 31, 2021 | -47.82% |
April 30, 2021 | -22.72% |
Date | Value |
---|---|
January 31, 2021 | -19.36% |
October 31, 2020 | -17.45% |
July 31, 2020 | -18.20% |
April 30, 2020 | -18.30% |
January 31, 2020 | -11.18% |
October 31, 2019 | -7.42% |
July 31, 2019 | -24.31% |
April 30, 2019 | -23.65% |
January 31, 2019 | -19.18% |
October 31, 2018 | -16.85% |
July 31, 2018 | -10.44% |
April 30, 2018 | -13.50% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-80.88%
Minimum
Apr 2022
-7.42%
Maximum
Oct 2019
-38.99%
Average
-34.86%
Median
Oct 2023
Profit Margin (Quarterly) Benchmarks
Teladoc Health Inc | -12.67% |
American Shared Hospital Services | 7.28% |
Novo Integrated Sciences Inc | -86.61% |
Astrana Health Inc | 3.50% |
Cryo-Cell International Inc | 7.08% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -52.07% |
Return on Assets | -37.83% |
Return on Invested Capital | -51.93% |
Gross Profit Margin (Quarterly) | 66.56% |
Operating Margin (Quarterly) | -31.13% |
Return on Net Operating Assets | -68.66% |